K. Sumegová

Inhibition of NF-κB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol)

J. Muchova, Z. Ďuračková, P. Högger, 2006, Journal of Inflammation.

Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol).

J. Muchova, Z. Ďuračková, P. Högger, 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Effect of pine bark extract (Pycnogenol®) on symptoms of knee osteoarthritis

J. Muchova, Z. Ďuračková, I. Waczulíková, 2008, Phytotherapy research : PTR.

Protein carbonyls as a biomarker of foetal-neonatal hypoxic stress.

M. Chavko, I. Žitňanová, Z. Ďuračková, 2007, Clinical biochemistry.

Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.

I. Žitňanová, Z. Ďuračková, I. Waczulíková, 2006, Acta biochimica Polonica.

Paraoxonase 1 (PON1) and its relationship to lipid variables, age and gender in healthy volunteers

Z. Ďuračková, I. Waczulíková, B. Fuhrman, 2006, Biologia.

Activity of paraoxonase 1 and lipid profile in healthy children.

I. Žitňanová, Z. Ďuračková, I. Waczulíková, 2007, Physiological research.

Single and multiple dose pharmacokinetics of maritime pine bark extract (Pycnogenol) after oral administration to healthy volunteers

J. Muchova, Z. Ďuračková, P. Högger, 2006, BMC clinical pharmacology.